CompletedNot Applicable

Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard Questionnaires

United Kingdom305 participantsStarted 2023-03-15

Plain-language summary

A cohort study comparing the novel 'Sexual Minorities and Prostate Cancer Scale' (SMACS) to the gold standard questionnaires investigating erectile dysfunction (IIEF) and incontinence (ICIQLUTSqol and ICIQ-UI) following robotic assisted radical prostatectomy

Who can participate

Age range40 Years – 75 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients attending for prostatectomy care at our institution Exclusion Criteria: * All non-English speakers

What they're measuring

The score for SMACS domains for sexual dysfunction compared to gold standard PROM for erectile function (IIEF) in a post-prostatectomy population

Timeframe: 10 months

The score for SMACS domains for incontinence compared to two gold standard PROMs for incontinence (ICIQLUTSqol, ICIQ-UI) in a post-prostatectomy population

Timeframe: 10 months

Trial details

NCT IDNCT05772598

SponsorGuy's and St Thomas' NHS Foundation Trust

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-08-02

View on ClinicalTrials.gov More Prostate Cancer trials